Chemistry: analytical and immunological testing – Composition for standardization – calibration – simulation,... – Preservative – buffer – anticoagulant or diluent
Reexamination Certificate
2007-04-10
2007-04-10
Wallenhorst, Maureen M. (Department: 1743)
Chemistry: analytical and immunological testing
Composition for standardization, calibration, simulation,...
Preservative, buffer, anticoagulant or diluent
C436S008000, C436S071000, C252S408100, C424S464000, C424S474000, C514S056000
Reexamination Certificate
active
10516858
ABSTRACT:
A solid heparin tablet composition has a melting point of 25° C. or higher and is a continuous lipid component containing one or more polar lipids, one or more non-polar lipids, optionally one or several of water and mono- to trivalent alcohol in an amount of up to 15% by weight of the composition, and native heparin or fractionated heparin. Also described is a corresponding tablet, processes for production of the composition and the tablet, and a method of preventing or treating conditions amenable to preventive or therapeutic treatment by administration of the tablet.
REFERENCES:
patent: 5082667 (1992-01-01), Van Scoik
patent: 5626869 (1997-05-01), Nyqvist et al.
patent: 5665379 (1997-09-01), Herslof et al.
patent: 5716639 (1998-02-01), Carlsson et al.
patent: 2003/0161884 (2003-08-01), Rosenberg et al.
patent: 2005/0020539 (2005-01-01), Ajani et al.
patent: 0368247 (1990-05-01), None
patent: WO-92/05771 (1992-04-01), None
patent: WO-93/19737 (1993-10-01), None
patent: 01/66086 (2001-09-01), None
patent: WO-01/91729 (2001-12-01), None
patent: WO-02/47663 (2002-06-01), None
patent: WO-03/49721 (2003-06-01), None
patent: 03/068267 (2003-08-01), None
European Journal of Pharmaceutical Sciences, vol. 1, 1994, L. Lohikangas et al.; “Relative contribution of phosphatidylcholine and monoglyceride to absorption enhancement of low molecular weight heparin (Fragmin) by a new lipid-based drug delivery system in monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits”; pp. 307-312, abstract 3.1, 3.3, discussion.
Herslöf Bengt
Tingvall Per
Dickstein , Shapiro, LLP.
LTP Lipid Technologies Provider AB
Wallenhorst Maureen M.
LandOfFree
Anticoagulant composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticoagulant composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticoagulant composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753993